Marksans Pharma Urges Shareholders for KYC Updates Ahead of IEPF Transfer
Marksans Pharma has initiated a shareholder engagement campaign urging investors to complete KYC updations and claim pending dividends before these are transferred to the Investor Education and Protection Fund (IEPF).
Read article